Berberine Inhibits Human Hepatoma Cell Invasion without Cytotoxicity in Healthy Hepatocytes
2011
Berberine Inhibits Hepatoma Cell Invasion
Sample size: 6
publication
Evidence: moderate
Author Information
Author(s): Liu Bing, Wang Genshu, Yang Jie, Pan Xuediao, Yang Zhicheng, Zang Linquan
Primary Institution: Guangdong Pharmaceutical University
Hypothesis
Does berberine have cytotoxic effects on healthy hepatocytes while inhibiting invasive hepatoma cells?
Conclusion
Berberine may be a potential alternative treatment for invasive hepatoma cells without harming healthy liver cells.
Supporting Evidence
- Berberine showed significant cytotoxicity in HepG2 cells but not in normal Chang liver cells.
- Berberine inhibited HepG2 cell invasion by suppressing MMP-9 expression.
- Combination treatment with pathway inhibitors enhanced the anti-invasive effects of berberine.
Takeaway
Berberine can help stop cancer cells from spreading without hurting normal liver cells.
Methodology
The study used MTT assays, ROS detection, and invasion assays to evaluate the effects of berberine on HepG2 and Chang liver cells.
Limitations
The findings may not be generalizable to other cell types beyond HepG2 and Chang liver cells.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website